China Sunsine Chemical Holdings Ltd. Just Beat EPS By 8.3%: Here's What Analysts Think Will Happen Next

China Sunsine Chemical Holdings Ltd. (SGX:QES) last week reported its latest annual results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. China Sunsine Chemical Holdings missed revenue estimates by 3.5%, with sales of CN¥2.3b, although statutory earnings per share (EPS) of CN¥0.23 beat expectations, coming in 8.3% ahead of analyst estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

See our latest analysis for China Sunsine Chemical Holdings

earnings-and-revenue-growth
SGX:QES Earnings and Revenue Growth February 28th 2021

Taking into account the latest results, the most recent consensus for China Sunsine Chemical Holdings from three analysts is for revenues of CN¥3.24b in 2021 which, if met, would be a substantial 39% increase on its sales over the past 12 months. Per-share earnings are expected to shoot up 45% to CN¥0.31. In the lead-up to this report, the analysts had been modelling revenues of CN¥3.01b and earnings per share (EPS) of CN¥0.28 in 2021. So there seems to have been a moderate uplift in sentiment following the latest results, given the upgrades to both revenue and earnings per share forecasts for next year.

Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of S$0.55, suggesting that the forecast performance does not have a long term impact on the company's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on China Sunsine Chemical Holdings, with the most bullish analyst valuing it at S$0.61 and the most bearish at S$0.47 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting China Sunsine Chemical Holdings' growth to accelerate, with the forecast 39% growth ranking favourably alongside historical growth of 6.1% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 15% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect China Sunsine Chemical Holdings to grow faster than the wider industry.

Advertisement

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards China Sunsine Chemical Holdings following these results. Happily, they also upgraded their revenue estimates, and are forecasting revenues to grow faster than the wider industry. The consensus price target held steady at CN¥0.55, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on China Sunsine Chemical Holdings. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for China Sunsine Chemical Holdings going out to 2023, and you can see them free on our platform here..

You should always think about risks though. Case in point, we've spotted 2 warning signs for China Sunsine Chemical Holdings you should be aware of.

If you decide to trade China Sunsine Chemical Holdings, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About SGX:QES

China Sunsine Chemical Holdings

An investment holding company, manufactures and sells specialty chemicals in the People’s Republic of China, rest of Asia, America, Europe, and internationally.

Flawless balance sheet, undervalued and pays a dividend.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5361.6% undervalued
143 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18054.9% undervalued
27 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.319.9% undervalued
15 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2449.4% undervalued
33 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

KA
kapirey
ATRL logo
kapirey on AtkinsRéalis Group ·

The commitment to nuclear power plants for electricity generation will fill AtkinsReális portfolio

Fair Value:CA$560.6284.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
PGHN logo
kapirey on Partners Group Holding ·

Partners Group Holding will achieve an 8.14% revenue rise over the next 5 years

Fair Value:CHF 68030.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
COPN logo
kapirey on Cosmo ·

Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates

Fair Value:CHF 10023.8% undervalued
84 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.6% undervalued
111 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74017.0% undervalued
39 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6116.1% undervalued
1185 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative